Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422AM1)(COMPLETED)
This study has been completed.
Study NCT00367237 Information provided by Schering-Plough
First Received: August 18, 2006 Last Updated: May 21, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arthritis, Psoriatic
Additional conditions recognized in this trial
Arthritis
More general conditions related to this trial
Bone Diseases
Joint Diseases
Musculoskeletal Diseases
Psoriasis
Skin Diseases
Skin Diseases, Papulosquamous
Spinal Diseases
Spondylarthritis
Spondylarthropathies
Interventions listed in this trial
Methotrexate (MTX)
Additional drug interventions recognized in this trial
Infliximab
Methotrexate
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Anti-Inflammatory Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Schering-Plough
Integrated Therapeutics Group
Back to top of Main Content
